Cisplatin‐mediated down‐regulation of miR‐145 contributes to up‐regulation of PD‐L1 via the c‐Myc transcription factor in cisplatin‐resistant ovarian carcinoma cells
出版年份 2019 全文链接
标题
Cisplatin‐mediated down‐regulation of miR‐145 contributes to up‐regulation of PD‐L1 via the c‐Myc transcription factor in cisplatin‐resistant ovarian carcinoma cells
作者
关键词
-
出版物
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2019-12-10
DOI
10.1111/cei.13406
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Recent Progress in Gene Therapy for Ovarian Cancer
- (2018) Ángela Áyen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Recent advances in searching c-Myc transcriptional cofactors during tumorigenesis
- (2018) Matteo Caforio et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
- (2018) Gang Chen et al. NATURE
- PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
- (2017) Sydney R. Gordon et al. NATURE
- New Dancing Couple: PD-L1 and MicroRNA
- (2017) A. Grenda et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Down regulation of miR-143 promotes radiation – Induced thymic lymphoma by targeting B7H1
- (2017) Hainan Zhao et al. TOXICOLOGY LETTERS
- Functional Expression of Programmed Death-Ligand 1 (B7-H1) by Immune Cells and Tumor Cells
- (2017) Rachel M. Gibbons Johnson et al. Frontiers in Immunology
- Comprehensive Immunohistochemical Study of Programmed Cell Death Ligand 1 (PD-L1)
- (2016) Shingo Inaguma et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Molecular mechanisms for tumour resistance to chemotherapy
- (2016) Shu-Ting Pan et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Anti-PD-L1/PD-1 immune therapies in ovarian cancer: basic mechanism and future clinical application
- (2016) Masaki Mandai et al. International Journal of Clinical Oncology
- Ovarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology
- (2016) Robert J. Morgan et al. Journal of the National Comprehensive Cancer Network
- MYC regulates the antitumor immune response through CD47 and PD-L1
- (2016) S. C. Casey et al. SCIENCE
- Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor- B to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer
- (2015) J. Peng et al. CANCER RESEARCH
- PDL1 Regulation by p53 via miR-34
- (2015) Maria Angelica Cortez et al. JNCI-Journal of the National Cancer Institute
- Ovarian cancer: beyond resistance
- (2015) David Holmes NATURE
- Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy
- (2015) Shabnam Shalapour et al. NATURE
- Overview of MicroRNA Biology
- (2015) Ashley Mohr et al. SEMINARS IN LIVER DISEASE
- Immune Checkpoint Protein Inhibition for Cancer: Preclinical Justification for CTLA-4 and PD-1 Blockade and New Combinations
- (2015) Kathryn Baksh et al. SEMINARS IN ONCOLOGY
- PDL1 Regulation by p53 via miR-34
- (2015) Maria Angelica Cortez et al. JNCI-Journal of the National Cancer Institute
- Paclitaxel Induced B7-H1 Expression in Cancer Cells via the MAPK Pathway
- (2014) Wenrong Gong et al. JOURNAL OF CHEMOTHERAPY
- Ovarian cancer
- (2014) Gordon C Jayson et al. LANCET
- MiR-145 is downregulated in human ovarian cancer and modulates cell growth and invasion by targeting p70S6K1 and MUC1
- (2013) Huijuan Wu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- miR145 Targets the SOX9/ADAM17 Axis to Inhibit Tumor-Initiating Cells and IL-6-Mediated Paracrine Effects in Head and Neck Cancer
- (2013) C.-C. Yu et al. CANCER RESEARCH
- Comparative microRNA Profiling of Prostate Carcinomas with Increasing Tumor Stage by Deep Sequencing
- (2013) Martin Hart et al. MOLECULAR CANCER RESEARCH
- Screening of differentially expressed microRNA in ulcerative colitis related colorectal cancer
- (2013) Yong-Gang Tan et al. Asian Pacific Journal of Tropical Medicine
- Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways
- (2012) Shunsuke Noguchi et al. CANCER LETTERS
- MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer
- (2011) Jelena Radojicic et al. CELL CYCLE
- MiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1
- (2011) William CS Cho et al. RNA Biology
- miRNA profiling along tumour progression in ovarian carcinoma
- (2010) Olga Vaksman et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Increased Frequency and Suppression by Regulatory T Cells in Patients with Acute Myelogenous Leukemia
- (2009) M. J. Szczepanski et al. CLINICAL CANCER RESEARCH
- MicroRNA Regulation of Oncolytic Herpes Simplex Virus-1 for Selective Killing of Prostate Cancer Cells
- (2009) C. Y. F. Lee et al. CLINICAL CANCER RESEARCH
- Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation
- (2009) William C.S. Cho et al. EUROPEAN JOURNAL OF CANCER
- p53 represses c-Myc through induction of the tumor suppressor miR-145
- (2009) M. Sachdeva et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ag-specific type 1 CD8 effector cells enhance methotrexate-mediated antitumor responses by modulating differentiated T cell localization, activation and chemokine production in established breast cancer
- (2008) Mark J. Dobrzanski et al. CLINICAL IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search